We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.1M
AUM Growth
+$3.38M
Cap. Flow
+$1.12M
Cap. Flow %
1.72%
Top 10 Hldgs %
32.36%
Holding
505
New
81
Increased
27
Reduced
140
Closed
15

Top Buys

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$935K
2
ANSS
Ansys
ANSS
+$934K
3
CDNS icon
Cadence Design Systems
CDNS
+$866K
4
MDLZ icon
Mondelez International
MDLZ
+$836K
5
NFLX icon
Netflix
NFLX
+$836K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.18M
2
GILD icon
Gilead Sciences
GILD
+$1.1M
3
ROST icon
Ross Stores
ROST
+$991K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$984K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$368K

Sector Composition

Rank Sector Weight
1 Healthcare 22.26%
2 Technology 14.97%
3 Industrials 14.19%
4 Consumer Discretionary 10.83%
5 Consumer Staples 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$120B
$3.46M 5.32%
9,834
-780
-7% -$263K
FISV
2
Fiserv Inc
FISV
$28.3B
$3.38M 5.18%
26,756
-909
-3% -$107K
BIIB icon
3
Biogen
BIIB
$30.2B
$2.42M 3.72%
8,508
-3,977
-32% -$1.18M
MNST icon
4
Monster Beverage
MNST
$94.5B
$2.2M 3.38%
38,367
-4,991
-12% -$284K
ROST icon
5
Ross Stores
ROST
$80.7B
$2.19M 3.36%
19,513
-9,426
-33% -$991K
GILD icon
6
Gilead Sciences
GILD
$162B
$2.1M 3.23%
27,283
-13,836
-34% -$1.1M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$76.2B
$1.95M 2.99%
2,712
-1,276
-32% -$984K
ACGL icon
8
Arch Capital
ACGL
$34.4B
$1.14M 1.75%
15,234
-514
-3% -$37.2K
LW icon
9
Lamb Weston
LW
$7.24B
$1.13M 1.74%
9,873
-554
-5% -$61.8K
MRK icon
10
Merck
MRK
$323B
$1.09M 1.68%
9,462
-1,757
-16% -$199K
BSX icon
11
Boston Scientific
BSX
$67.1B
$1.09M 1.68%
20,171
-425
-2% -$22.2K
CPRT icon
12
Copart
CPRT
$26.9B
$1.03M 1.58%
+22,550
New +$935K
NVDA icon
13
NVIDIA
NVDA
$4.76T
$1.01M 1.55%
23,810
+23,630
+13,128% +$785K
NFLX icon
14
Netflix
NFLX
$298B
$1,000K 1.54%
22,700
+22,690
+226,900% +$836K
GWW icon
15
W.W. Grainger
GWW
$65.4B
$977K 1.5%
1,239
-30
-2% -$20.7K
ANSS
16
DELISTED
Ansys
ANSS
$974K 1.5%
+2,948
New +$934K
CMI icon
17
Cummins
CMI
$88.2B
$950K 1.46%
3,874
-736
-16% -$167K
CDNS icon
18
Cadence Design Systems
CDNS
$92.8B
$935K 1.44%
3,988
+3,978
+39,780% +$866K
AVGO icon
19
Broadcom
AVGO
$1.84T
$914K 1.4%
10,540
+10,490
+20,980% +$748K
BWA icon
20
BorgWarner
BWA
$13B
$901K 1.38%
20,922
-919
-4% -$37.8K
PCG icon
21
PG&E
PCG
$38.5B
$883K 1.36%
51,078
-12,210
-19% -$207K
TJX icon
22
TJX Companies
TJX
$175B
$869K 1.33%
10,249
-2,277
-18% -$180K
MDLZ icon
23
Mondelez International
MDLZ
$79.7B
$828K 1.27%
11,345
+11,315
+37,717% +$836K
EG icon
24
Everest Group
EG
$14.5B
$817K 1.25%
2,390
-53
-2% -$19.1K
APD icon
25
Air Products & Chemicals
APD
$65.5B
$809K 1.24%
2,702
-557
-17% -$159K
1
2 3 4 5

Similar funds

EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return

USA Financial Formulas's Q2 2023 Portfolio in Review

As of Q2 2023, USA Financial Formulas held 505 positions worth $65.1M, up 5.5% from $61.7M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

USA Financial Formulas's Q2 2023 filing shows 81 new, 27 increased, 140 reduced and 15 closed positions. Its largest new stake was Copart: 22,550 shares worth $1.03M. The largest sale was Biogen, an estimated $1.18M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • USA Financial Formulas's largest Q2 2023 buy was Copart: 22,550 shares worth $1.03M.
  • USA Financial Formulas added most to Cadence Design Systems in Q2 2023, an estimated $866K increase.
  • USA Financial Formulas's biggest Q2 2023 reduction was Biogen, cutting an estimated $1.18M.
  • USA Financial Formulas fully exited Northrop Grumman in Q2 2023, selling an estimated $23.1K.
  • USA Financial Formulas's ten largest holdings make up 32% of its $65.1M portfolio in Q2 2023.
  • USA Financial Formulas opened 81 new positions and closed 15 in Q2 2023.
  • USA Financial Formulas's portfolio value rose 5.5% quarter-over-quarter to $65.1M.

Based on USA Financial Formulas's 13F filing for Q2 2023, filed 27 Nov 2023.